Combined ivermectin and intense pulsed light therapy can help resolve Demodex blepharitis and prevent its recurrence.

This article highlights clinical and economic factors associated with Demodex blepharitis as well as diagnostic complexities, limitations of traditional therapies, the safety and efficacy of the 1 ...

Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...

In addition to Demodex blepharitis, Tarsus has a pipeline of ... increased 12-fold with FDA approval of the first drug specific for that condition, reaching more than 6 million diagnoses per ...

An expert provides insights into the cost of misdiagnosed Demodex blepharitis and payer considerations for a potential cost-effective treatment. Eric D. Donnenfeld, MD; underscores the ...

Position Trading Today, the company sells one drug that could, potentially, treat 25 million people in the U.S. with Demodex blepharitis, a condition that occurs when mites build up in the eyelashes.

Additionally, the synergistic effect of perfluorohexyloctane and meibum highlights the drug’s excellent therapeutic action as an anti-evaporative agent. Lotilaner also demonstrated a favorable safety ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

Dr. Orr: "Eyelash extensions can indeed cause Blepharitis ... Treatment for ocular Demodex typically involves an ...

The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...